Ultima-Primo 200

ULTIMA-PRIMO 200 BY ULTIMA PHARMACEUTICALS

Injectable Oily Solution

DRUG COMPOSITION

1 mL of solution contains:
- active substance: methenolone enanthate 200 mg;
- auxiliary substances:

DRUG DESCRIPTION

Transparent oily solution, from yellow to light yellow color, with characteristic smell.

PHARMACEUTICAL FORM

Injectable oily solution.

PHARMACEUTICAL GROUP AND ATC CODE

Androgen; Anabolic Steroid; Androgen Ester.

PHARMACOLOGICAL PROPERTIES

PROFILE

Half life: 5-7 Days
Routes of administration: intramuscular injection
Dosage forms: (Men): 300-800 mg/week; (Women): -
Acne: yes
Water retention: low
High blood pressure: perhaps
Hepatotoxicity: low
Aromatase: no
Decreased HPTA function (own testosterone production): yes
Anabolic activity: 88%
Androgenic activity: 44%
Detection time:

THERAPEUTICAL INDICATIONS

DOSES AND METHOD OF ADMINISTRATION

SIDE EFFECTS

CONTRAINDICATIONS

OVERDOSE

INTERACTIONS WITH OTHER DRUGS

PRESENTATION, PACKAGING

Injectable oily solution 200 mg / 1 mL in 10 mL Vial vials.

STORAGE

Store in a dry place and away from light at 15-25 ° C. Keep out of the reach and sight of children.

LEGAL STATUS

It is issued with prescription.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Ultima Pharmaceuticals
Europe